\
&
Contact us
\
&
Contact us
This was 7 months ago
LocationBrussels
The next Science for health conference, jointly organised by Medvia and BioWin, will discuss how AI, data & digitalisation can accelerate innovation in drug discovery & development and prevention & diagnostics. With a wide range of speakers and case studies, focus will be on how these digital technologies can help revolutionising the healthcare of today and tomorrow.
The conference brings together academics, industry leaders and policymakers every year to tackle health challenges and spark new research collaborations. During past editions, over 300 people united to form connections in Belgium and beyond.
More information, the conference programme and registration on the event's website. Note that this is a paying event.
Background: The Science for health conference is organised jointly by Medvia and BioWin. Medvia is the innovation cluster of Flanders for better health. It facilitates & supports collaborations among healthtech companies. BioWin is the Health Cluster of Wallonia. It is the regional reference holder for all stakeholders in innovative R&I projects in health biotechnology and medical technologies.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security Digital, Industry & Space Cybersecurity
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
